Monica Hernandez-Arenas
Guys & St Thomas' NHS Foundation Trust
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world data.
Journal: British journal of clinical pharmacology
Published: July 23, 2025
Personalizing Biologic Therapy in Psoriasis: Development, Validation, and User Testing of a Precision-Dosing Dashboard.
Journal: The Journal of investigative dermatology
Published: November 27, 2024
cPMP rescue of a neonate with severe molybdenum cofactor deficiency after serendipitous early diagnosis, and characterisation of a novel MOCS1 variant.
Journal: Molecular genetics and metabolism
Published: August 20, 2024
Reducing risk in thiopurine therapy.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: November 05, 2019
A practical guide to thiopurine prescribing and monitoring in IBD.
Journal: Frontline gastroenterology
Published: July 27, 2016
Adenine phosphoribosyltransferase deficiency in the United Kingdom: two novel mutations and a cross-sectional survey.
Journal: Clinical kidney journal
Published: February 29, 2016
Getting the best out of thiopurine therapy: thiopurine S-methyltransferase and beyond.
Journal: Biomarkers in medicine
Published: January 22, 2015
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity.
Journal: British journal of cancer
Published: June 06, 2013
Mechanism of allopurinol induced TPMT inhibition.
Journal: Biochemical pharmacology
Published: April 19, 2013
Let's get personal: predicting thiopurine and fluoropyrimidine toxicity.
Journal: Personalized medicine
Published: November 01, 2012
The pharmacogenetic basis of individual variation in thiopurine metabolism.
Journal: Personalized medicine
Published: September 01, 2012
Last Updated: 09/26/2026